Skip to main content

Table 3 Baseline characteristics in users and non-users of fish oil supplements: the Tromsø Study

From: Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study

 

Fish oil supplements

Yes

n = 1627

No

n = 1663

p

Age, y

61.4 (0.2)

60.6 (0.2)

0.0007

Male, %

49.0

55.7

0.0001

Higher education, %a

25.0

16.0

< 0.0001

Physical active, %

27.2

23.0

0.005

BMI, kg/m2

25.6 (0.1)

26.3 (0.1)

< 0.0001

Total cholesterol, mmol/L

6.73 (0.03)

6.80 (0.03)

0.09

LDL cholesterol, mmol/L

4.43 (0.03)

4.48 (0.03)

0.2

HDL cholesterol, mmol/L

1.57 (0.01)

1.55 (0.01)

0.3

LDL/HDL ratio

3.09 (0.03)

3.12 (0.09)

0.4

Triglycerides, mmol/L

1.61 (0.03)

1.70 (0.03)

0.02

Systolic blood pressure, mmHg

144.6 (0.5)

145.4 (0.5)

0.2

Diastolic blood pressure, mmHg

83.5 (0.3)

84.0 (0.3)

0.2

Hypertension, %

54.1

55.8

0.3

Current smoking, %

28.7

34.8

0.0002

Coffee consumption, cups/d

 Boiled coffee

2.3 (0.09)

3.5 (0.09)

< 0.0001

 Other coffee

2.9 (0.08)

2.6 (0.08)

0.009

Diabetes, %

2.1

2.4

0.6

Antihypertensive medication, %

10.4

9.5

0.4

Lipid-lowering medication, %b

2.0

1.1

0.04

Leucocyte count, × 109/L

6.80 (0.05)

6.95 (0.05)

0.02

Monocyte count, ×  109/L

0.58 (0.004)

0.59 (0.004)

0.04

Fibrinogen, g/L

3.33 (0.02)

3.40 (0.02)

0.01

LogCRP, mg/L

0.20 (0.03)

0.27 (0.03)

0.04

  1. Age was sex-adjusted and sex was age- adjusted. All other variables were age- and sex-adjusted means (SE) or %
  2. BMI body mass index
  3. aCollege or university
  4. bParticipants < 70 years